These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 19608019)

  • 41. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease.
    Musso G; Gambino R; Durazzo M; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Rabbione L; Premoli A; Cassader M; Pagano G
    Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum lipid pattern in chronic hepatitis C: histological and virological correlations.
    Siagris D; Christofidou M; Theocharis GJ; Pagoni N; Papadimitriou C; Lekkou A; Thomopoulos K; Starakis I; Tsamandas AC; Labropoulou-Karatza C
    J Viral Hepat; 2006 Jan; 13(1):56-61. PubMed ID: 16364083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma.
    Chen CH; Lin ST; Kuo CL; Nien CK
    Hepatogastroenterology; 2008; 55(85):1423-7. PubMed ID: 18795704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C.
    Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F
    Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum leptin levels in patients with nonalcoholic steatohepatitis.
    Uygun A; Kadayifci A; Yesilova Z; Erdil A; Yaman H; Saka M; Deveci MS; Bagci S; Gulsen M; Karaeren N; Dagalp K
    Am J Gastroenterol; 2000 Dec; 95(12):3584-9. PubMed ID: 11151896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: therapeutic implications for hepatitis C.
    Wedemeyer I; Bechmann LP; Odenthal M; Jochum C; Marquitan G; Drebber U; Gerken G; Gieseler RK; Dienes HP; Canbay A
    J Hepatol; 2009 Jan; 50(1):140-9. PubMed ID: 19019483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Splanchnic concentrations and postprandial release of visceral adipokines.
    Wiest R; Moleda L; Farkas S; Scherer M; Kopp A; Wönckhaus U; Büchler C; Schölmerich J; Schäffler A
    Metabolism; 2010 May; 59(5):664-70. PubMed ID: 19913846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
    Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
    Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.
    Kara B; Gunesacar R; Doran F; Kara IO; Akkiz H
    Adv Ther; 2007; 24(5):972-82. PubMed ID: 18029322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between adipokines and manifestations of childhood asthma.
    Kim KW; Shin YH; Lee KE; Kim ES; Sohn MH; Kim KE
    Pediatr Allergy Immunol; 2008 Sep; 19(6):535-40. PubMed ID: 18221467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors affecting the serum levels of adipokines in Korean male patients with nonalcoholic fatty liver disease.
    Cho YK; Lee WY; Oh SY; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Kim SW; Oh KW; Yun EJ; Oh ES
    Hepatogastroenterology; 2007; 54(77):1512-6. PubMed ID: 17708287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adiponectin and its receptors in patients with chronic hepatitis C.
    Jonsson JR; Moschen AR; Hickman IJ; Richardson MM; Kaser S; Clouston AD; Powell EE; Tilg H
    J Hepatol; 2005 Dec; 43(6):929-36. PubMed ID: 16139921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Steatosis in chronic viral hepatitis C: frequency, risk factors and relationship with fibrosis].
    Karoui S; Taieb Jomni M; Bellil K; Haouet S; Boubaker J; Filali A
    Tunis Med; 2008 Jul; 86(7):670-5. PubMed ID: 19472729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum adiponectin in chronic hepatitis C and B.
    Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
    J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
    Cua IH; Hui JM; Bandara P; Kench JG; Farrell GC; McCaughan GW; George J
    Hepatology; 2007 Jul; 46(1):66-73. PubMed ID: 17596870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.
    Gaslightwala I; Bini EJ
    J Hepatol; 2006 Jun; 44(6):1026-32. PubMed ID: 16618518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.